Bank of New York Mellon
CPXX

Bank of New York Mellon’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bank of New York Mellon’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-139,790
Closed -$4.22M – 4385
2016
Q2 		$4.22M Buy
139,790
+29,690
+27% +$602K ﹤0.01% 2296
2016
Q1 		$1.21M Buy
110,100
+88,227
+403% +$289K ﹤0.01% 2947
2015
Q4 		$38K Sell
21,873
-50
-0.2% -$86 ﹤0.01% 4218
2015
Q3 		$36K Buy
+21,923
New +$48.7K ﹤0.01% 4280

Bank of New York Mellon's CPXX Position: Q3 2016 in Review

Bank of New York Mellon sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 139,790 shares — an estimated $4.22M sold.

Bank of New York Mellon first reported a position in CPXX in Q3 2015 and held it in 4 quarters. The position peaked at $4.22M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Bank of New York Mellon reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 139,790 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $4.22M.
  • Bank of New York Mellon first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2015 and held it in 4 quarters.
  • Bank of New York Mellon's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $4.22M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Bank of New York Mellon's 13F filing for Q3 2016, filed 3 Nov 2016.